Latest News

Thursday, August 25, 2016 | Research and Publications

MR-Guided Focused Ultrasound Shows Promise in Treatment of Essential Tremor

New findings published in The New England Journal of Medicine suggest that MR-guided Focused Ultrasound therapy may represent a viable non-invasive treatment option for the treatment of essential trem…

Read the full story

Thursday, August 25, 2016 | Research and Publications

Expert Panel Calls for Increase in Comparative Effectiveness Research for Alzheimer’s Disease

With effective prevention and treatment of Alzheimer’s disease (AD) still elusive, an expert panel recently called for a boost in comparative effectiveness research as part of a larger effort to…

Read the full story

Tuesday, August 23, 2016 | Research and Publications

Deep Brain Stimulation Shows Promise in TBI

A new study suggests that Deep Brain Stimulation (DBS) may improve the quality of life and functioning of people with severe disability from traumatic brain injury (TBI). The findings, published in th…

Read the full story

Tuesday, August 23, 2016 | FDA Approval/Clearance, Pfizer

FDA Approves Abuse Deterrent Troxyca ER for Pain Management

The FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride, Pfizer) extended-release capsules for the management of pain severe enough to require daily long-term opioid trea…

Read the full story

Wednesday, August 17, 2016 | Research and Publications

Spinal Cord Stimulation Therapy Found Effective for Chronic Headache

The long-term benefits and safety that has been observed in patients receiving high cervical spinal cord stimulation for back and/or leg pain may also carry over to chronic refractory headac…

Read the full story

Tuesday, August 16, 2016 | Research and Publications

Parkinson’s Biomarkers Take Shape as Imaging Results Identify Alterations in Brain Activity

New findings demonstrating the extent to which Parkinson’s disease (PD) alters brain activity over time may represent an important step in identifying therapies that slow disease progression. Us…

Read the full story

Tuesday, August 09, 2016 | Phase 3/4 Trials, Biogen

Investigational BACE Inhibitor for Early Alzheimer’s Disease Moves to Phase 3 Trials

An investigational BACE inhibitor for the treatment of early Alzheimer’s disease is moving into Phase 3 trials, following confirmation from the FDA. Developed in a partnership between Eisai and …

Read the full story

Monday, August 08, 2016 | Personnel/Company News

Quest Diagnostics Introduces Digital Testing Technology for Cognitive Dysfunction

Quest Diagnostics has launched a digital testing technology designed to aid in the assessment, diagnosis, and care for patients with cognitive dysfunction. Recently unveiled at the Alzheimer’s A…

Read the full story

Friday, July 29, 2016 | Healthcare Trends

AAN Issues New Guidelines on Treating Stroke Patients with PFO

The American Academy of Neurology (AAN) is cautioning against the routine use of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke, according to its new guidelines…

Read the full story

Wednesday, July 27, 2016 | Phase 3/4 Trials

AAIC 2016: Six-Year Data Show that Vascular Care Intervention May Reduce non-Alzheimer’s Dementia

Findings from Prevention of Dementia By Intensive Vascular Care (preDIVA) trial, presented at the 2016 Alzheimer’s Association International Conference (AAIC) in Toronto suggests that while a va…

Read the full story

Tuesday, July 26, 2016 | Phase 3/4 Trials

New Findings Link ALS Risk to Two Genes

Researchers from an international consortium headed by the University Medical Center (UMC) Utrecht have discovered two new ALS genes, both of which have the potential to increase the risk of ALS signi…

Read the full story

Tuesday, July 26, 2016 |

AAIC 2016: Eye and Smell Tests Show Potential for Alzheimer’s Detection

New evidence presented at the Alzheimer's Association International Conference (AAIC) 2016 suggests the potential for odor identification testing and physical changes in and around the eye to…

Read the full story

Monday, July 25, 2016 | Healthcare Trends

AAIC 2016: Active Treatment of Alzheimer's Disease Reduces Healthcare Costs

New data presented at the ongoing Alzheimer’s Association International Conference (AAIC) 2016 in Toronto suggests that non-treatment of Alzheimer's disease may increase the burden of h…

Read the full story

Tuesday, July 19, 2016 | FDA Approval/Clearance

Ultrasound Treatment for Essential Tremor Wins FDA Approval

The FDA approved Insightec’s Exablate Neuro system, a technology that uses focused ultrasound waves for the non-invasive treatment of essential tremor (ET) in patients who have not responded to …

Read the full story

Tuesday, July 19, 2016 | Business of Medicine, Personnel/Company News

Monteris Medical Appoints Martin J. Emerson President and CEO

Monteris Medical's Board of Directors has appointed Martin J. Emerson as President and Chief Executive Officer effective immediately.  Monteris Medical is a privately hel…

Read the full story
Load More